CARMOT THERAPEUTICS INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • November 17th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of __________, and is between Carmot Therapeutics Inc., a Delaware corporation (together with its subsidiaries, the “Company”), and __________ (“Indemnitee”).
CARMOT THERAPEUTICS INC.Stock Option Agreement • November 17th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • California
Unless otherwise defined herein, the terms defined in the 2008 Stock Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
SUB-SUBLEASESub-Sublease • November 17th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • California
CONSULTING AGREEMENTConsulting Agreement • November 17th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”) is made and entered into as of January 31, 2023 (the “Effective Date”) by and between Carmot Therapeutics, Inc. (the “Company”), and Stig Hansen (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”).
CARMOT THERAPEUTICS INC.Equity Incentive Plan • November 17th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • California
Unless otherwise defined herein, the terms defined in the 2018 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
CARMOT THERAPEUTICS INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 28th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of May 24, 2023, by and among Carmot Therapeutics Inc., a Delaware corporation (the “Company”), the investors listed on Exhibit A hereto, each of which is herein referred to as an “Investor,” and Daniel A. Erlanson and Stig K. Hansen, each of whom is herein referred to as a “Founder.”
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • September 28th, 2023 • Carmot Therapeutics Inc. • Pharmaceutical preparations • California
This Separation Agreement and Release (“Agreement”) is made by and between Stig Hansen (“Employee”) and Carmot Therapeutics, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
